Anaconda BioMed, a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical to develop, test and manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical phases. “This is another important step for Anaconda Biomed to secure …
Recent Comments